Brief: Bayer Completes Acquisition Of Perfuse Therapeutics
17/06/2026 07:32
BRIEF-Bayer Completes Acquisition Of Perfuse Therapeutics June 17 (Reuters) - BAYER AG BAYGn.DE:
BAYER COMPLETES ACQUISITION OF PERFUSE THERAPEUTICS
DEAL VALUED UP TO $2.45 BILLION WITH $300 MILLION UPFRONT PAYMENT
Source text: ID:nBw1NzYM5a
Further company coverage: [BAYGn.DE]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Bayer AG
See all newsBayer takes a giant leap toward investability
Europe Research Roundup: Barratt Redrow, Ferrari, KPN
Explainer: What does Bayer's US Supreme Court win mean for the thousands of Roundup lawsuits?
Bayer shares soar over 18% after U.S. Supreme Court curbs Roundup lawsuits
US Supreme Court scales back Roundup cancer suits in win for Bayer (updated)